Drugs, and therapies involving the use of antidepressants or steroids, antipsychotics, opioids, and the application of electroshock therapy, lobotimes, leucotimes all ultimately have one effect in common. This is in calming a patient which is accomplished by the bran dysfunctioning caused by these drugs.
However useful at the time to control a patient’s activity, these drugs and their actual nature is not considered health profitable in terms of brain quality in the long-term. Currently, the Psychiatric Drugs market consists of ten classes of prescription drugs that effectively impair brain functioning. The pharmaceutical industry offers such medications in Psychiatric as well as non-drug category.
These drugs are used to treat a large number of symptoms along with their claim to treat the cognitive impairments which are caused due to depression or schizophrenia.The non-drug therapies targeting brain impairment such as electroshock therapy (ECT) or lobotimes also have displayed side effects in the past. For instance, in the past, a physician induced the hospitalized schizophrenic patients with malaria and won a Nobel Prize for it despite the several deaths that were caused.